Print

Print


Glad you are still holding the fort, Rayilyn. It's been a long time
maryse

On Sat, 1 Feb 2020 at 08:00, Rayilyn Brown <[log in to unmask]> wrote:

> Hi Maryse -           Ive wondered what has happened to everybody.
> wish I    had good      news, Ray
>
> On 1/31/2020 2:40 AM, Maryse Schild wrote:
> > Hi to you, Ray and Nic. ( and anyone still on this list). Good to have
> some
> > news.
> >
> > maryse
> >
> > On Fri, 31 Jan 2020 at 08:00, Rayilyn Brown <[log in to unmask]> wrote:
> >
> >> Hi Nic - my  24th has been my worst year yet/I dont pst much cause it
> >> iw          so ohard to use the computer
> >> -             see               what I mean?Amantadine        improved
> >> my mmmobiliity but gave me hhhhhhhhhhhhhhorrible hallllucinations.  I
> >> take Rimantadine which doesn't help           much            but Idont
> >> have side effects,I also  take Rytary but cant wal
> >> k                             but a step or two/worst problem ois
> >> inbility to speak well eenooough to be             understood.
> >>
> >> Time sure   does fly               -       suddenly  at 84     Ima n
> >> elder....was 60   when diagnosed/my computer guy has
> >> parkinsonnnnnnnnnn's and he   is   55.  I  feel so ba d for him. He
> >> has          bilateral tremprs     but can still funnction.
> >>
> >> good to  hear from you.Ray
> >>
> >> On 1/30/2020 6:43 AM, Nic Marais wrote:
> >>> Hi Ray! How are you? Scary how time flies... In April this year it
> >>> will be 26 years since iI was diagnosed at age 42.
> >>> I still halucinate a lot, but I stick to my amantidine. It smooths the
> >>> dyskineasias out, and improves my mobility.
> >>> regards
> >>>
> >>> Nic 67/25
> >>>
> >>> On Thu, Jan 30, 2020, 09:00 Rayilyn Brown <[log in to unmask]
> >>> <mailto:[log in to unmask]>> wrote:
> >>>
> >>>      -------- Forwarded Message --------
> >>>      Subject:        Google Alert - Parkinson's Disease vaccine
> >>>      Date:   Wed, 29 Jan 2020 20:01:51 -0800
> >>>      From:   Google Alerts <[log in to unmask]
> >>>      <mailto:[log in to unmask]>>
> >>>      To: [log in to unmask] <mailto:[log in to unmask]>
> >>>
> >>>
> >>>
> >>>
> >>>              Google
> >>>      <
> >>
> https://www.google.com/alerts?source=alertsmail&hl=en&gl=US&msgid=OTEzMjY2MDQ1MDIxODU0NzIzNQ
> >>>
> >>>
> >>>
> >>>              Parkinson's Disease vaccine
> >>>      Daily update ⋅ January 30, 2020
> >>>
> >>>
> >>>              NEWS
> >>>
> >>>
> >>>      FDA Response Bolsters Affiris' Plans for Potential *Parkinson's
> >>>      Vaccine*
> >>>      Affitope
> >>>      <
> >>
> https://www.google.com/url?rct=j&sa=t&url=https://parkinsonsnewstoday.com/2020/01/29/fda-response-affiris-phase-2-trial-parkinsons-vaccine-affitope/&ct=ga&cd=CAEYACoTOTEzMjY2MDQ1MDIxODU0NzIzNTIaZDQ1NzQ0OTU2MTY4OTQ5MDpjb206ZW46VVM&usg=AFQjCNGzyxpZrS304gRc-6nTbEPuMt3YZg
> >>>
> >>>
> >>>      Parkinson's News Today
> >>>      The U.S. Food *and* Drug Administration (FDA) has responded to
> >>>      Affiris'
> >>>      pre-investigational new drug (IND) submission regarding a planned
> >>>      Phase
> >>>      2 ...
> >>>      Facebook
> >>>      <
> >>
> https://www.google.com/alerts/share?hl=en&gl=US&ru=https://parkinsonsnewstoday.com/2020/01/29/fda-response-affiris-phase-2-trial-parkinsons-vaccine-affitope/&ss=fb&rt=FDA+Response+Bolsters+Affiris%27+Plans+for+Potential+Parkinson%27s+Vaccine+Affitope&cd=KhM5MTMyNjYwNDUwMjE4NTQ3MjM1MhpkNDU3NDQ5NTYxNjg5NDkwOmNvbTplbjpVUw&ssp=AMJHsmWGqzhRMojb11NN3_I7xS6zEtzVSw
> >>>
> >>>              Twitter
> >>>      <
> >>
> https://www.google.com/alerts/share?hl=en&gl=US&ru=https://parkinsonsnewstoday.com/2020/01/29/fda-response-affiris-phase-2-trial-parkinsons-vaccine-affitope/&ss=tw&rt=FDA+Response+Bolsters+Affiris%27+Plans+for+Potential+Parkinson%27s+Vaccine+Affitope&cd=KhM5MTMyNjYwNDUwMjE4NTQ3MjM1MhpkNDU3NDQ5NTYxNjg5NDkwOmNvbTplbjpVUw&ssp=AMJHsmWGqzhRMojb11NN3_I7xS6zEtzVSw
> >>>
> >>>              Flag as irrelevant
> >>>      <
> >>
> https://www.google.com/alerts/feedback?ffu=https://parkinsonsnewstoday.com/2020/01/29/fda-response-affiris-phase-2-trial-parkinsons-vaccine-affitope/&source=alertsmail&hl=en&gl=US&msgid=OTEzMjY2MDQ1MDIxODU0NzIzNQ&s=AB2Xq4gAqFpiEZgPmXEXWHydIwUEe0beJ8zfJlw
> >>>
> >>>
> >>>
> >>>
> >>>      See more results
> >>>      <
> >>
> https://www.google.com/alerts?s=AB2Xq4gAqFpiEZgPmXEXWHydIwUEe0beJ8zfJlw&start=1579665849&end=1580356911&source=alertsmail&hl=en&gl=US&msgid=OTEzMjY2MDQ1MDIxODU0NzIzNQ#history
> >>>
> >>>      | Edit this alert
> >>>      <
> >>
> https://www.google.com/alerts/edit?source=alertsmail&hl=en&gl=US&msgid=OTEzMjY2MDQ1MDIxODU0NzIzNQ&s=AB2Xq4gAqFpiEZgPmXEXWHydIwUEe0beJ8zfJlw&email=rayilynlee%40cox.net
> >>>
> >>>
> >>>
> >>>      You have received this email because you have subscribed to
> *Google
> >>>      Alerts*.
> >>>      Unsubscribe
> >>>      <
> >>
> https://www.google.com/alerts/remove?source=alertsmail&hl=en&gl=US&msgid=OTEzMjY2MDQ1MDIxODU0NzIzNQ&s=AB2Xq4gAqFpiEZgPmXEXWHydIwUEe0beJ8zfJlw
> >>>
> >>>      | View all your alerts
> >>>      <
> >>
> https://www.google.com/alerts?source=alertsmail&hl=en&gl=US&msgid=OTEzMjY2MDQ1MDIxODU0NzIzNQ
> >>>
> >>>
> >>>      RSS Receive this alert as RSS feed
> >>>      <
> >>
> https://www.google.com/alerts/feeds/04082120950631708698/17975067122935243170
> >>>
> >>>
> >>>      Send Feedback
> >>>      <
> >>
> https://www.google.com/alerts?source=alertsmail&hl=en&gl=US&msgid=OTEzMjY2MDQ1MDIxODU0NzIzNQ&s=AB2Xq4gAqFpiEZgPmXEXWHydIwUEe0beJ8zfJlw&ffu=
> >>>
> >>>
> >>>
> >>>
> >>>
> >>   ----------------------------------------------------------------------
> >>>      To sign-off Parkinsn send a message to:
> >>>      mailto:[log in to unmask]
> >>>      <mailto:[log in to unmask]>
> >>>      In the body of the message put: signoff parkinsn
> >>>
> >> ----------------------------------------------------------------------
> >> To sign-off Parkinsn send a message to: mailto:
> >> [log in to unmask]
> >> In the body of the message put: signoff parkinsn
> >>
> > ----------------------------------------------------------------------
> > To sign-off Parkinsn send a message to: mailto:
> [log in to unmask]
> > In the body of the message put: signoff parkinsn
>
> ----------------------------------------------------------------------
> To sign-off Parkinsn send a message to: mailto:
> [log in to unmask]
> In the body of the message put: signoff parkinsn
>

----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn